Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials.
Saved in:
| Title: | Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials. |
|---|---|
| Authors: | Johnson D; Institute of Translational Medicine, Department of Biostatistics, University of Liverpool, Waterhouse Building, 1-5 Brownlow Street, Liverpool L69 3GL, UK. danielle.johnson@liverpool.ac.uk., Hughes D; Centre for Health Economics and Medicines Evaluation, Bangor University, Ardudwy, Normal Site, Bangor LL57 2PZ, UK., Pirmohamed M; MRC Centre for Drug Safety Science and Wolfson Centre for Personalised Medicine, Institute of Translational Medicine, Waterhouse Building, 1-5 Brownlow Street, Liverpool L69 3GL, UK., Jorgensen A; Institute of Translational Medicine, Department of Biostatistics, University of Liverpool, Waterhouse Building, 1-5 Brownlow Street, Liverpool L69 3GL, UK. |
| Source: | Journal of personalized medicine [J Pers Med] 2019 Sep 01; Vol. 9 (3). Date of Electronic Publication: 2019 Sep 01. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2075-4426 |
|---|---|
| DOI: | 10.3390/jpm9030042 |
